A 3-arm randomized control trial to compare the efficacy of re-circulant hyperthermic intravesical chemotherapy versus conventional intravesical mitomycin C and BCG therapy for intermediate-risk non-muscle invasive bladder cancer
Crossref DOI link: https://doi.org/10.1007/s00345-024-05338-x
Published Online: 2024-10-31
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sachan, Ankit
Nayyar, Rishi
Pethe, Sahil
Singh, Prashant
Seth, Amlesh
Text and Data Mining valid from 2024-10-31
Version of Record valid from 2024-10-31
Article History
Received: 9 June 2024
Accepted: 22 October 2024
First Online: 31 October 2024
Declarations
:
: The authors declare no competing interests.